Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 2 of 122
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Sobi agrees $8bn takeover offer from Advent and GIC

Swedish Orphan Biovitrum (Sobi) has agreed a $8bn (SEK69.4bn) takeover offer from Advent International and Singapore’s wealth fund GIC. Sobi’s board of directors had unanimously recommended that shareholders